Atlas Trials

Pleural Malignant Mesothelioma

8 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Pleural Malignant Mesothelioma

RecordFirmDate
Pembrolizumab With or Without Anetumab Ravtansine in Treating Patients With Mesothelin-Positive Pleural Mesothelioma (NCT03126630)National Cancer Institute (NCI)2018-10-04
Confocal Laser Endomicroscopy in Pleural Malignancies (NCT03290183)Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)2017-08-28
Pembrolizumab After Radiation Therapy in Treating Patients With Pleural Malignant Mesothelioma (NCT02959463)M.D. Anderson Cancer Center2017-05-01
Accelerated Hypofractionated Radiation Therapy Immediately Before Surgery in Treating Patients With Malignant Pleural Mesothelioma (NCT02672033)Jonsson Comprehensive Cancer Center2015-09-01
Pembrolizumab in Treating Patients With Malignant Mesothelioma (NCT02399371)University of Chicago2015-03-31
Anti-TGF Monoclonal Antibody (GC1008) in Relapsed Malignant Pleural Mesothelioma (NCT01112293)Abramson Cancer Center at Penn Medicine2010-04-01
Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma (NCT01064648)National Cancer Institute (NCI)2010-03-15

Track Pleural Malignant Mesothelioma automatically

Every clearance here is in the API, with alerts when new ones post.